Feed/Investors/Mass General Brigham Ventures

Mass General Brigham Ventures

The rounds this investor is named on, who it invests beside, and where it shows up.

Named on one round in the feed.

Corporate venture armmassgeneralbrigham.orgSince 2025-02-12

ROUNDS

joined, none as lead

ROUNDS JOINED · USD

$200M

across 1 round

LATEST ROUND

Series C · $200M · 2025-02-12

CO-INVESTORS

named beside it

Rounds

The rounds this investor is named on, who it invests beside, and where it shows up.

Breakthrough therapies for autoimmune diseases and cancer for patients with specific conditions.

Series C$200M2025-02-122 [ HISTORY ]

Company	Round	Amount	Announced	Role
Abcuro.com Breakthrough therapies for autoimmune diseases and cancer for patients with specific conditions.	Series C Verified against 2 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it.	$200M	2025-02-12	[ PART ]